News

Yossi discusses his principal goals and motivations for writing this latest book that resulted in record turnaround time. We discuss the before and after COVID-19 aspects of industry supply chains, why certain approaches were successful in terms of business process practices, innovation and resourcefulness of supply chain management teams, as well as leveraged use of technology.

It's been nearly 10 months since Covid-19 slammed into the global economy like a wrecking ball. And while businesses have learned to manage, many will endure lasting effects that may take years to resolve. In the meantime, all of us—businesses and consumers alike—are yearning for things to get back to normal. But what does that even mean? Is it possible that we may someday return to some semblance of our old lives? Or will we enter a "new normal"? And if so, what will that look like?

The FDA officially granted emergency use authorization for the Pfizer-BioNTech COVID-19 vaccine on Friday, writing that “in making this determination, the FDA can assure the public and medical community that it has conducted a thorough evaluation of the available safety, effectiveness and manufacturing quality information.

Extreme lockdown measure in Germany are coming up. In the US, hospitalizations keep breaking records. The good news is Pfizer begins shipping its vaccine.

Sessions during the summit put some of today’s game-changing strategies and digital solutions into perspective and offer practical tips for evaluating, implementing and leveraging today’s technology to streamline operations and build resilience into your supply chain.

Professor Yossi Sheffi offers us a session that takes a look at how the pandemic has actually accelerated the acceptance of new supply chain technology and intelligence tools. 

Mobilization involves factory workers, truck drivers, pilots, dry ice, ultracold freezers and plenty of needles. A lot can go wrong. To work, every one of the many and complicated links of the chain has to hold.

When Pfizer Inc. said last month it expected to ship half the Covid-19 vaccines it had originally planned for this year, the decision highlighted the challenges drug makers face in rapidly building supply chains to meet the high demand.

Whether it’s appliances, groceries, electronics, toys, or hardware supplies, most retailers have been affected in some way by COVID-19′s disruption to the global supply chain... Dr. Yossi Sheffi, an MIT professor who specializes in supply chain management, said reduced air travel is going to impact items imported from overseas, like iPhones and computer chips.

Our discussion touches on lessons for corporate executives, technology startup founders and even early-stage supply chain technology venture capitalists. We also touch on themes that regular readers of this column will find familiar.

Supply chains have been in the spotlight like never before over the last eight months. That hasn’t always been a good thing. The perception, reinforced by shortages of products essential to our daily lives, is that supply chains were not up to the task and failed.